Business Wire

Xilam Extends Oggy into Mobile Games with Nazara Partnership

Jaa

Regulatory News:

Xilam Animation (Paris:XIL) is further boosting the Oggy & the Cockroaches brand into gaming with the appointment of Nazara Technologies Ltd, a global mobile game company, in a deal brokered via Xilam and licensing agent, Dream Theatre.

Nazara will launch a raft of new captivating mobile games for younger audiences that underscore the hilarious, entertaining brand values of Oggy & the Cockroaches. The first game is expected to be available in the first quarter of 2018 in Asia Pacific, Latin America and Middle East.

With an ever-growing digital landscape, Oggy & the Cockroaches is reaching new heights and raking up exceptional results on digital platforms throughout the world. The series has a cult following on Facebook with more than 3.5M fans and 1.2M subscribers on YouTube. Partnering with Nazara is only a natural extension of the brand experience.

Marc du Pontavice, Founder and President of Xilam said: “Xilam is eager to expand the presence of its properties in the digital domain. Nazara is one of the leaders in the mobile gaming arena and we’re thrilled to be working together to take Oggy and his friends to new heights in gaming. We’re excited to give kids yet another avenue to become immersed in his cheeky world as we celebrate 20 years of Oggy & the Cockroaches.”

Nazara is one of the leading mobile games company’s in India's digital landscape, operating in 61 countries across emerging markets, as of September 30, 2017. In India, Nazara has licensed mobile gaming rights to popular kids IPs including Chhota Bheem, Motu Patlu, Mighty Raju, Tinkle characters and Chacha Choudhary among other IP’s including Virat Kohli, Royal Challengers Bangalore and Hrithik Roshan.

Manish Agarwal, CEO, Nazara Technologies said: “With Oggy & the Cockroaches, Nazara will continue to deliver high-quality games for the global market. We have built a strong portfolio of successful games which have targeted young audiences in India over the last two years and now with the Oggy & the Cockroaches IP, we can reach audiences across emerging markets beyond India, by leveraging the global appeal of the show. ”

Cartoon Network Asia has scooped up seasons five, six and seven of the series for its channels this year, with previous seasons of Oggy currently running on Nickelodeon, Youku in China and Netflix Asia Pacific (outside China and India).

In India, Oggy & the Cockroaches currently airs on both Cartoon Network and Nickelodeon, as well as on Amazon Prime. The series is also available on Cartoon Network Latin America and on Cartoon Network Middle East and Africa (MENA), and Gulli Bil Arabi.

The series is distributed in more than 160 countries around the world and is watched in 600 million homes.

About Xilam

Xilam is one of Europe’s leading animation companies, producing and distributing original children’s and family entertainment content in both 2D and CGI formats across TV, film and digital media platforms. Founded in 1995 by Marc du Pontavice, the award-winning Paris-based company owns a catalogue of more than 2,000 animated episodes and 3 feature films including strong brands such as Oggy & the Cockroaches, Zig & Sharko, The Daltons, Rolling with the Ronks and its first pre-school property, Paprika.

Broadcast in over 160 countries on all the major global children’s TV networks, these series are also breaking records on all the major digital platforms, including YouTube with over 250 million views per month, ranking Xilam as one of the top global content providers in animation.

Xilam employs more than 400 people, including 300 artists, who are based across its four studios located in Paris, Lyon, Angoulême and Hô-Chi-Minh Ville in Vietnam.

About Nazara Technologies

Nazara is a mobile games company headquartered in Mumbai, India and has operations in 61 countries across emerging markets, as on September 30, 2017. Nazara runs mobile gaming subscription services to mass mobile internet users comprising largely of first time mobile gamers across Africa, Middle East, South East Asia, Latin America and the Indian subcontinent. In India, Nazara has licensed mobile gaming rights to popular IP’s like Virat Kohli, Hrithik Roshan, Chhota Bheem, Royal Challengers Bangalore, Motu Patlu, Mighty Raju, Tinkle Characters and Chacha Choudhary.

Nazara was one of the leading publishers by downloads on Google Play Store with more than 22 million downloads in India in the calendar year 2016 and the company crossed over 34 million downloads in the calendar Year 2017 until September 30, 2017. Nazara had over 10 million monthly active users in September 2017 across its network of games on Google Play Store.

86 / 90 rue notre Dame de Nazareth 75003 Paris - Tél : (33) 01 40 18 72 00 - Fax : (33) 01 40 03 02 26
www.xilam.com
Société Anonyme au capital de 446 500 € - R.C.S PARIS : 423 784 610 - SIRET : 423 784 610 00036 - APE 921 A

Contact information

Press:
DDA Blueprint:
Eva Pitarides, +44 20 7932 9800
xilam@ddapr.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Takeda Receives Clearance from the European Commission for the Proposed Acquisition of Shire plc20.11.2018 17:33Tiedote

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Takeda Pharmaceutical Company Limited (“Takeda”) announces that it has received clearance from the European Commission (the “EC”) for the proposed acquisition of Shire plc (“Shire”) announced on May 8, 2018 (the “Acquisition”). The EC’s approval is conditional on Takeda and Shire fulfilling commitments given to the EC in connection with the clearance. Specifically, in relation to the future potential overlap in the area of inflammatory bowel diseases between Takeda’s marketed product Entyvio (vedolizumab) and Shire’s pipeline compound SHP647, Takeda and Shire have committed to divest the pipeline compound SHP647 and certain associated rights. The divestment of SHP647 and certain associated rights is not a condition to the completion of the Acquisition. SHP647 is an exciting pipeline compound

ResMed Elects Harjit Gill to Its Board of Directors20.11.2018 17:05Tiedote

ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service business solutions, today announced it has elected experienced consumer and healthcare executive Harjit Gill to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005179/en/ Harjit Gill, BA (Photo: Business Wire) Ms. Gill was elected by shareholders at its annual shareholder meeting last week in Sydney, Australia. Also, announced at that meeting, Gary W. Pace has retired from ResMed’s board after serving on it since July 1994. Ms. Gill’s appointment and Dr. Pace’s retirement both took effect Thursday, November 15. Ms. Gill has more than 25 years’ experience in health and consumer technology products as an executive, investor and regional business leader spanning Asia, Europe and the Middle East. From 1990 to 2015, she worked for Royal Philips as executive vice president and CEO for Phi

PTC Adds Artificial Intelligence and Generative Design Capabilities to Enhance and Expand its CAD Portfolio with Acquisition of Frustum20.11.2018 15:12Tiedote

PTC (NASDAQ: PTC) today announced that it has acquired Frustum Inc., an advanced generative design software company, for approximately $70 million. Frustum’s technology for generative design—an approach that leverages artificial intelligence (AI) to generate design options—is a transformative addition to the PTC Creo portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005326/en/ PTC Adds Artificial Intelligence and Generative Design Capabilities to Enhance and Expand its CAD Portfolio with Acquisition of Frustum (Graphic: Business Wire) Based in Boulder, Colorado, Frustum offers patented desktop and cloud-based engineering software that enables designers and engineers to go beyond the limits of their personal experience by leveraging powerful AI capabilities that guide the discovery of high-performance, next-generation product designs. “PTC is pushing the boundaries of innovation with this acquisition,” said Jim

United First Partners Launches UFP Fintech20.11.2018 15:00Tiedote

United First Partners (“UFP”), a leading independent Research, Brokerage, Advisory & Investment group is pleased to announce the launch of its latest venture: UFP Fintech. UFP Fintech invests in early stage Fintech, Proptech and Legaltech startups. Under the leadership of the entity’s CIO Christophe Petetin, a veteran investor in the Fintech space with an unparalleled investment track record in Fintech start-ups, UFP Fintech aims to become a global leader in Early Stage Fintech Investments. In recent years, Christophe and the UFP Fintech team have seeded a major unicorn and several other market leading entities. Christophe is a premier Fintech thought leader, who also acts in an advisory capacity to governmental and regulatory bodies, such as the FCA and ISO 20022 to create the next generation of standards for Fintech, payments, data, securities & digital currencies. Christophe commented “The financial industry is getting rebuilt from the ground up creating unprecedented opportunities.

LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases20.11.2018 14:00Tiedote

Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm today announced a strategic development and commercialization collaboration to address unmet medical needs across various skin diseases with no approved treatments, advancing innovation and access to potential therapies for patients with life-altering conditions, such as Gorlin Syndrome and High Frequency Basal Cell Carcinoma (BCC), two distinct and rare forms of skin cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005227/en/ “We are very excited about the partnership with PellePharm, who are pioneers in Gorlin Syndrome and experts in rare skin diseases. Supporting our ambitious 2025 strategy, it marks LEO Pharma’s entrance in rare skin diseases and it offers a unique opportunity to bring the first treatment forward to people suffering from a very severe skin disease for which there currently are no approved therapies,” sai

IDEMIA Provides SK Telecom in South Korea with GMSA Compliant Smart Connect Solution to Activate and Manage eSIM Device Lifecycles20.11.2018 12:00Tiedote

IDEMIA, the global leader in Augmented Identity, is proud to have been selected by SK Telecom, the number one telecommunication operator in South Korea, to launch the first eSIM Connected watch based on GSMA Consumer standards. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181120005231/en/ Crédits : IDEMIA As a leading actor in the telecom field, IDEMIA is at the forefront of the digital revolution and is committed to bringing protected and convenient experiences to mobile operator customers. Leveraging its industrial leadership and appetite for innovation, IDEMIA will be providing SK Telecom its GSMA compliant solution. Based on IDEMIA’s Smart Connect Subscription management solution also known as remote SIM provisioning, the technology remotely connects the eSIM of the smart watch to the SK Telecom’s network without inserting a physical SIM card. This technology is also compliant with the latest GSMA standards ensuring in

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme